Bluejay Diagnostics Corp - BJDX Sales Growth YoY (TTM)

Brandmark of bluejaydx.com (BJDX)

Bluejay Diagnostics (BJDX) is developing the Symphony platform for instantaneous blood analysis in intensive care units. The company accumulates its primary capital through the sale of portable devices and disposable cartridges for rapid diagnostics. A narrow specialization in sepsis creates binary risks, which the year-over-year product sales dynamics for TTM confirm, as the indicator remains at 0.00.

bluejaydx.com (BJDX) Sales Growth YoY (Last Twelve Months): for the period 02/11/2024 - 11/15/2026

Bluejay Diagnostics Corp - analytical breakdowns and key metrics (BJDX)

- stock price and consensus target price:
Price Chart Bluejay Diagnostics|BJDX - Consensus Target
- issuer market value details:
Market Capitalization Bluejay Diagnostics, Inc.|BJDX - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share Bluejay Diagnostics|BJDX - Company Book Value|Market Cap to Book Value Multiple bluejaydx.com|BJDX - Company Total Assets
- business debt structure and liquidity details:
Total Debt to Capital Bluejay Diagnostics|BJDX - Long-Term Debt to Equity Ratio|Current Liabilities to Capital Bluejay|BJDX - Company Total Debt|Debt to Net Assets Ratio Bluejay Diagnostics, Inc.|BJDX - Company Long-Term Debts|Company Short-Term Indebtedness Bluejay Diagnostics|Interim Coverage Ratio bluejaydx.com
- earnings and market multiples details:
BJDX - Net Profit|Projected Future Earnings Bluejay Diagnostics|BJDX - P/E Multiple|Forward Price to Earnings Multiple bluejaydx.com|BJDX - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Bluejay Diagnostics Inc|BJDX - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Bluejay Diagnostics|BJDX - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months bluejaydx.com|BJDX - Net earnings per share growth this year|Projected earnings per share increase next year Bluejay Diagnostics
- sales and revenue data:
BJDX - Revenue and Sales Volume|Company Future Sales Bluejay|BJDX - P/S Multiple|Forward Price-to-Revenue Multiple Bluejay Diagnostics Inc|BJDX - Sales Growth YoY (Last Twelve Months)
Fundamental company valuation:Bluejay
Original product of Bluejay

For Bluejay Diagnostics (BJDX), the expansion of Symphony systems into intensive care units correlates directly with revenue dynamics, confirming market dominance in the rapid sepsis diagnostics niche. By analyzing the TTM sales growth, an investor can observe the percentage change in revenue over a rolling year, which neutralizes seasonality and quarterly distortions, allowing for an assessment of the business's fundamental resilience to macroeconomic shocks.

Who Bluejay Diagnostics competes with

Agilent Corp (A) - Trailing Twelve Months Revenue Growth|DGX - Sales Growth YoY (Last Twelve Months)|ILMN: Sales Growth YoY (Last Twelve Months)|EXAS: Sales Growth YoY (TTM)|RVTY (Revvity) - Sales Growth YoY (Last Twelve Months)|BIO (Bio-Rad Laboratories, Inc.) - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Anbio Biotechnology NNNN|Revenue Growth YoY (Last 12 Months) SHC (Sotera Health Company)|Sales Growth YoY (Last Twelve Months) QDEL (quidel.com)|Sales Growth YoY (TTM) OPK (opko.com)|Revenue Dynamics YoY (Last Twelve Months) CDNA|MRVI: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) FLGT (Fulgent Corp)|LAB: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth cytekbio.com (CTKB)|OSUR (OraSure Corp) - Sales Growth YoY (TTM)|Exagen (XGN) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) MDxHealth, Inc. (MDXH)|Lucid Diagnostics, Inc - Sales Growth YoY (Last 12 Months)|Sales Growth YoY (Last Twelve Months) Prenetics PRE|Insight Molecular (IMDX) - Trailing Twelve Months Revenue Growth|Trinity Biotech Corp - Sales Growth YoY (TTM)|Annual Revenue Growth (Last Twelve Months) ProPhase PRPH|AIMD: Sales Growth YoY (TTM)|CODX - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Heart Test Laboratories, Inc.|Sales Growth YoY (Last Twelve Months) BMRA|Sales Growth YoY (TTM) CDIO|Onconetix - Sales Growth YoY (Last 12 Months)|Sales Growth YoY (Last Twelve Months) viraxbiolabs.com VRAX|Aspira Women's Health - Sales Growth YoY (Last Twelve Months)|AXDX - Sales Growth YoY (Last Twelve Months)|Revenue Growth Rate YoY (Last Twelve Months) Centogene NV (CNTG)|ENZ (Enzo Biochem) - Revenue Growth YoY (Last 12 Months)|fresh2.co (FRES) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) Genetic Technologies Limited|Trailing Twelve Months Revenue Growth 23andMe Inc. ME|Sales Growth YoY (Last Twelve Months) Psychemedics (PMD)